Clinical trials of the drug have shown mixed results.
The first drug targeting Alzheimer's disease has been approved in 20 years – but its approval isn't based on substantial evidence.
It was first officially described 115 years ago, but we still do not have a cure for Alzheimer's disease. The human brain is extremely complex, and Alzheimer’s is its most complex disease.
The researchers developed a molecule which works to stop toxic proteins from building up in the brain.
We now have the technology to identify people who are on a fast track to developing dementia.
Protein tangles have been blamed for causing Alzheimer's – but drugs that target them keep failing.
An important cell function called endocytosis is revealing a lot about how Alzheimer's develops.